Abstract
This chapter describes a historical program to improve management of patients at risk of stroke. While guidelines for management of stroke have changed since the time of this program, the value of this piece of work lies in the detail provided on the methods and utilisation of formative research, program design and program evaluation. Of particular note, is the evaluation of the impact of the program on health outcomes at a population level, which is the ultimate goal of many programs and yet one that we cannot always measure. Stroke is a common health event, and it causes significant morbidity and mortality. Preventative management in high-risk individuals is known to reduce the likelihood of stroke, and yet primary care doctors only implement guidelines in about 60% of patients. This chapter describes a large multifaceted intervention to improve prescribing in patients at risk of stroke. It outlines the rationale for topic selection, the use of formative research to design key messages, as well as process and summative evaluations. This program was able to show changes in clinicians’ knowledge, changes in prescribing of clopidogrel and changes in hospitalisation due to stroke at a population level.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Notes
- 1.
Guidelines for management and prevention of stroke have changed since this program was developed.
- 2.
An encounter is a visit to or consultation with the GP for management of this problem.
- 3.
The Pharmaceutical Benefits Scheme incorporates a Safety Net which is the maximum annual out-of-pocket expense that an individual will incur. Medication use in excess of the Safety Net is fully subsidized by the government.
References
45 and Up Study Collaborators, Banks, E., Redman, S., Jorm, L., Armstrong, B., Bauman, A., Lujic, S. (2008). Cohort profile: The 45 and up study. International Journal of Epidemiology, 37(5), 941–947. https://doi.org/10.1093/ije/dym184.
Australian Bureau of Statistics. (2009). Causes of death (Vol. Cat. no. 3303.0). Canberra: ABS.
Australian Institute of Health and Welfare. (2006). How we manage stroke in Australia (Vol. Cat. no. CVD 31). Canberra: AIHW.
Australian Institute of Health and Welfare. (2008). Australia’s health (Vol. No. 11). Canberra: AIHW.
Australian Institute of Health and Welfare. (2011). Cardiovascular disease: Australian facts (Vol. Cat. no. CVD 53). Canberra: AIHW.
Cardiovascular Expert Group. (2008). Therapeutic guidelines: cardiovascular. In eTG complete [CD-ROM] (Vol. Version 5, July 2008). Melbourne: Therapeutic Guidelines Limited.
French, S. D., Green, S. E., O’Connor, D. A., McKenzie, J. E., Francis, J. J., Michie, S., et al. (2012). Developing theory-informed behaviour change interventions to implement evidence into practice: A systematic approach using the theoretical domains framework. Implementation Science, 7, 38. https://doi.org/10.1186/1748-5908-7-38.
Hankey, G. J., & Eikelboom, J. W. (2003). Antiplatelet drugs. Medical Journal of Australia, 178(11), 568–574.
Henderson, J., & Pan, Y. (2009). Cardiovascular problems. In H. Britt & G. Miller (Eds.), General practice in Australia, health priorities and policy 1998 to 2008 (Vol. General practice series no. 24. Cat. no. GEP 24). Canberra: AIHW.
Jackson, S. L., Peterson, G. M., Vial, J. H., Daud, R., & Ang, S. Y. (2001). Outcomes in the management of atrial fibrillation: Clinical trial results can apply in practice. Journal of Internal Medicine, 31(6), 329–336.
Kleinig, T. J., Kimber, T. E., & Thompson, P. D. (2009). Stroke prevention and stroke thrombolysis: quantifying the potential benefits of best practice therapies. Medical Journal of Australia, 190(12), 678–682.
Kubler, P. A., Pillans, P. I., Marrinan, M. C., & Frogley, M. (2004). Concordance between clopidogrel use and prescribing guidelines. Journal of Internal Medicine, 34(12), 663–667. https://doi.org/10.1111/j.1445-5994.2004.00697.x.
Liu, Z., Moorin, R., Worthington, J., Tofler, G., Bartlett, M., Khan, R., & Zuo, Y. (2016). Using large-scale linkage data to evaluate the effectiveness of a national educational program on antithrombotic prescribing and associated stroke prevention in primary care. Journal of the American Heart Association, 5(10). https://doi.org/10.1161/jaha.116.003729.
Michie, S., Johnston, M., Francis, J., Hardeman, W., & Eccles, M. P. (2009). From theory to intervention: Mapping theoretically derived behavioural determinants to behaviour change techniques. Applied Psychology: An International Review, 57, 660–680.
National Institute of Clinical Studies. (2008). Evidence-practice gaps report: A review of developments 2004–2007. Canberra: NHMRC.
National Stroke Foundation. (2008). Clinical guidelines for stroke and TIA management: A guide for general practice. Canberra: National Stroke Foundation.
Neurology Expert Group. (2008). Therapeutic guidelines: Neurology. In eTG complete [CD-ROM] (Vol. Version 3, July 2008). Melbourne: Therapeutic Guidelines Limited.
Peterson, G. M., Boom, K., Jackson, S. L., & Vial, J. H. (2002). Doctors’ beliefs on the use of antithrombotic therapy in atrial fibrillation: Identifying barriers to stroke prevention. Internal Medicine Journal, 32(1–2), 15–23.
Senes, S., & Penm, E. (2007). Medicines for cardiovascular health: are they used appropriately? (Vol. Cardiovascular disease series no. 27. Cat. no. 36). Canberra: AIHW.
Wagner, A. K., Soumerai, S. B., Zhang, F., & Ross-Degnan, D. (2002). Segmented regression analysis of interrupted time series studies in medication use research. Journal of Clinical Pharmacy and Therapeutics, 27(4), 299–309.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2020 Springer Nature Singapore Pte Ltd.
About this chapter
Cite this chapter
Dartnell, J., Heaney, A., Liu, Z. (2020). A Program to Improve Use of Antithrombotic Medicines and Reduce the Incidence of Stroke. In: Weekes, L. (eds) Improving Use of Medicines and Medical Tests in Primary Care. Springer, Singapore. https://doi.org/10.1007/978-981-15-2333-5_10
Download citation
DOI: https://doi.org/10.1007/978-981-15-2333-5_10
Published:
Publisher Name: Springer, Singapore
Print ISBN: 978-981-15-2332-8
Online ISBN: 978-981-15-2333-5
eBook Packages: MedicineMedicine (R0)